Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Eleven brands across six molecules, made almost entirely by two companies Novo Nordisk and Eli Lilly: Semaglutide (Novo Nordisk) Ozempic, Wegovy, Rybelsus Tirzepatide (Eli Lilly) Mounjaro, Zepbound Liraglutide (Novo Nordisk) Victoza, Saxenda Dulaglutide (Eli Lilly) Trulicity Exenatide (AstraZeneca) Byetta, Bydureon BCise Lixisenatide (Sanofi) Adlyxin, no longer marketed in the US For weight management , the FDA has approved Wegovy, Zepbound and Saxenda
Kt qu khc nhau ty thuc vo tng ngi
As of June 1, 2026, there are 3,848 lawsuits pending in the federal multidistrict litigation (MDL) for general GLP-1 drug injuries and 146 pending lawsuits in the GLP-1 vision loss (NAION) MDL
And as youre already starting to see, theres lots of overlap
Blood pressure reduction: GLP-1 medications typically reduce systolic blood pressure by 4-6 mmHg
US$ 22.33
US$ 28.50
US$ 29.15
US$ 20.36
US$ 24.41
US$ 21.71
US$ 21.81
US$ 23.50
US$ 27.90
US$ 24.29
